Brief: Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya

Tonix Pharmaceuticals Holding

04/11/2024 15:33

Nov 4 (Reuters) - Tonix Pharmaceuticals Holding Corp
 TNXP.O :
    * TONIX PHARMACEUTICALS ANNOUNCES RESEARCH AGREEMENT WITH
KENYA
MEDICAL RESEARCH INSTITUTE (KEMRI) TO DESIGN, PLAN AND SEEK
REGULATORY APPROVAL FOR A PHASE I CLINICAL STUDY OF TNX-801 FOR
MPOX IN KENYA
    * TONIX PHARMACEUTICALS HOLDING CORP - TO TEST TNX-801
VACCINE FOR
MPOX IN KENYA
    * TONIX PHARMACEUTICALS HOLDING CORP - TO SPONSOR, KEMRI TO
LEAD
CLINICAL TRIAL FOR TNX-801

Source text:  ID:nGNX9yLBWY 
Further company coverage:  TNXP.O 

 ((Reuters.Briefs@thomsonreuters.com;))